ABSTRACT
Objective We recently developed a noninvasive method for quantifying neural synchrony in the cochlear nerve (i.e., peripheral neural synchrony) in cochlear implant (CI) users, which allows for evaluating this important physiological phenomenon in human CI users for the first time in the literature. This paper reports this new method in detail. In addition, this study assessed how peripheral neural synchrony was correlated with temporal resolution acuity and speech perception outcomes measured in quiet and in noise in post-lingually deafened adult CI users. It tested the hypotheses that 1) the degree of peripheral neural synchrony varied among CI users, and 2) peripheral neural synchrony was an important factor for temporal resolution acuity and speech perception outcomes in noise in post-lingually deafened adult CI users.
Design Study participants included 18 post-lingually deafened adult CI users with a Cochlear™ Nucleus® device. Two study participants were implanted bilaterally, and each ear was tested separately. For each of the 20 ears tested in this study, peripheral neural synchrony, quantified using an index named the phase locking value (PLV), was measured at four electrode locations across the electrode array (default electrodes: 3, 9, 15 and 21) based on 400 sweeps of the electrically evoked compound action potential (eCAP). The PLV is a measure of trial-by-trial phase coherence among eCAP sweeps/trials and quantifies the degree of peripheral neural synchrony. Temporal resolution acuity was evaluated by measuring the within-channel gap detection threshold (GDT) using a three-alternative, forced-choice procedure, targeting 79.4% correct on the psychometric function in a subgroup of 9 participants (10 ears). For each ear tested in these participants, GDTs were measured at two electrode locations with a large difference in PLVs. For 15 ears tested in 14 participants, speech perception performance was evaluated using Consonant-Nucleus-Consonant (CNC) word lists presented in quiet and in noise at signal-to-noise ratios (SNRs) of +10 and +5 dB. A Linear Mixed-effects Model (LMM) was used to evaluate the effect of electrode location on the PLV after controlling for the stimulation level effect. A partial correlation test was used to evaluate the association between the PLV and GDT while controlling for the effect of stimulation level on GDT. GDTs measured for electrode pairs with different PLVs were compared using a paired-samples t-test. The association between PLVs and CNC word scores measured in different conditions, as well as the association between the PLV and the degree of noise effect on CNC word scores were evaluated using Pearson product-moment correlation tests with Bonferroni correction for multiple comparisons.
Results PLVs varied substantially across study participants and electrode locations. There was a significant correlation between the PLV and GDT, where higher PLVs were associated with lower GDTs. PLVs were not significantly correlated with CNC word scores measured in any listening condition or the effect of competing background noise presented at a SNR of +10 dB on CNC word scores. In contrast, there was a moderate, negative correlation between the PLV and the degree of noise effect on CNC word scores for a competing background noise presented at a SNR of +5 dB.
Conclusions This newly developed method can be used to assess peripheral neural synchrony in living CI users, a physiological phenomenon that potentially plays a vital role in determining auditory perception outcomes in electrical hearing. Poorer peripheral neural synchrony is associated with lower temporal resolution acuity and larger detrimental effect of competing background noise on speech perception performance in post-lingually deafened adult CI users.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the National Institutes of Health awarded to SH [grant numbers 1R01 DC016038, 1R01 DC017846, R21 DC019458] and a NSERC Discovery Grant awarded to ICB [grant number RGPIN-2018-05778].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Biomedical Institutional Review Board of The Ohio State University gave ethical approval for this work (2017H0131).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of Interest: None.
Source of Funding: This work was supported by grants from the National Institutes of Health awarded to SH [grant numbers 1R01 DC016038, 1R01 DC017846, R21 DC019458] and a NSERC Discovery Grant awarded to ICB [grant number RGPIN-2018-05778].
Data Availability
Please contact the corresponding author to discuss access to the data presented in this study.